Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_assertion description "[Our findings suggest that ERK1/2, Akt, and NF-?B inhibitors are potentially useful as anti-MDR agents for the treatment of vincristine-resistant MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_assertion evidence source_evidence_literature NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_assertion SIO_000772 25726084 NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_assertion wasDerivedFrom befree-2016 NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_assertion wasGeneratedBy ECO_0000203 NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.
- befree-2016 importedOn "2016-02-19" NP1267097.RAhms88PARn-pPQnycqgW6DArE7FoaY8hh4k1AsgsCk7M130_provenance.